3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

By afschroeder • June 12, 2025

Eleid MF, Krishnaswamy A, Kapadia S, Yadav P, Rajagopal V, Makkar R, Stinis C, Chetcuti S, Morse A, Frisoli T, Frangieh AH, Abbas AE, Whisenant B, O'Neill WW, Guerrero ME, Rodriguez E, Kodali S, Ailawadi G, Rihal CS. 3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States. JACC Cardiovasc Interv. 2025 Jun 9;18(11):1454-1466. doi: 10.1016/j.jcin.2025.03.017. PMID: 40500016.

Tags: bioprosthetic mitral degeneration, Cardiology/Epi, Cedars Sinai DoM, mitral valve reintervention, mitral valve-in-valve procedure, Publications, Society for Thoracic Surgeons, Transcatheter Valve Therapy Registry, transseptal approach

Related Posts

FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494

Holzgreve A, Unterrainer LM, Flores K, Lam EC, Mona CE, Czernin J, Shuch BM, Sisk AE Jr, Calais J. FAP Expression in Renal Tumors Assessed[...]

Akebia Saponin D Targeting Ubiquitin Carboxyl-Terminal Hydrolase 4 Promotes Peroxisome Proliferator-Activated Receptor Gamma Deubiquitination and Activation of Brown Adipose Tissue Thermogenesis in Obesity

Chen L, Liu DH, Li YX, Yang S, Jia WH, Peng L, Liu HL, Wang XB, Hu B, Wang YC, Pan C, Lusis AJ, Liu[...]

The relationship between blood eosinophil count and cardiovascular outcomes in prediabetes and diabetes patients with acute coronary syndrome: insights from a large Asian cohort analysis

Feng X, Liu Y, Qin H, Zhao S, Yang J, Yang S, Zhou Z, Liu Y, Wang Z, Shi D, Zhou Y, Guo Q. The[...]